ArticleCancers2023

Clinical Characteristics, Response to Platinum-Based Chemotherapy and Poly (Adenosine Phosphate-Ribose) Polymerase Inhibitors in Advanced Lung Cancer Patients Harboring BRCA Mutations.

Johnathan Arnon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.